Hamid Masoudi

1.9k total citations
28 papers, 1.6k citations indexed

About

Hamid Masoudi is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Hamid Masoudi has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Molecular Biology. Recurrent topics in Hamid Masoudi's work include Thyroid Cancer Diagnosis and Treatment (10 papers), HER2/EGFR in Cancer Research (6 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). Hamid Masoudi is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (10 papers), HER2/EGFR in Cancer Research (6 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). Hamid Masoudi collaborates with scholars based in Canada, United States and Denmark. Hamid Masoudi's co-authors include Sam M. Wiseman, Pedro Farinha, Randy D. Gascoyne, Joseph M. Connors, Karey Shumansky, Karamjit Gill, Samuel Leung, Brian Skinnider, John J. Spinelli and Richard Klasa and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Hamid Masoudi

27 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hamid Masoudi Canada 17 741 663 361 349 304 28 1.6k
Fatima Rangwala United States 14 618 0.8× 557 0.8× 421 1.2× 260 0.7× 86 0.3× 34 1.6k
Susan J. Hsiao United States 18 615 0.8× 444 0.7× 150 0.4× 217 0.6× 163 0.5× 49 1.3k
Armelle Logié United Kingdom 19 962 1.3× 442 0.7× 206 0.6× 161 0.5× 86 0.3× 33 1.6k
Rajiv Bassi United States 19 925 1.2× 783 1.2× 226 0.6× 108 0.3× 232 0.8× 26 1.7k
Kathryn O’Reilly United States 7 1.8k 2.4× 563 0.8× 109 0.3× 318 0.9× 152 0.5× 15 2.2k
Michelle Kuhne United States 14 933 1.3× 788 1.2× 106 0.3× 177 0.5× 1.1k 3.5× 35 2.2k
Ellen Leich Germany 23 606 0.8× 557 0.8× 121 0.3× 546 1.6× 217 0.7× 50 1.4k
Khuda Dad Khan United States 16 622 0.8× 715 1.1× 74 0.2× 251 0.7× 512 1.7× 29 1.5k
Carlos García-Echeverría Switzerland 6 1.2k 1.6× 393 0.6× 164 0.5× 226 0.6× 95 0.3× 9 1.5k
Xenia Jimenez United States 22 1.2k 1.6× 670 1.0× 201 0.6× 89 0.3× 182 0.6× 27 1.7k

Countries citing papers authored by Hamid Masoudi

Since Specialization
Citations

This map shows the geographic impact of Hamid Masoudi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamid Masoudi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamid Masoudi more than expected).

Fields of papers citing papers by Hamid Masoudi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamid Masoudi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamid Masoudi. The network helps show where Hamid Masoudi may publish in the future.

Co-authorship network of co-authors of Hamid Masoudi

This figure shows the co-authorship network connecting the top 25 collaborators of Hamid Masoudi. A scholar is included among the top collaborators of Hamid Masoudi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamid Masoudi. Hamid Masoudi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Bing, Sarah Line Skovbakke, Hamid Masoudi, Robert E. W. Hancock, & Henrik Franzyk. (2020). In vivo Anti-inflammatory Activity of Lipidated Peptidomimetics Pam-(Lys-βNspe)6-NH2 and Lau-(Lys-βNspe)6-NH2 Against PMA-Induced Acute Inflammation. Frontiers in Immunology. 11. 2102–2102. 15 indexed citations
3.
Honig, Asaf, et al.. (2019). Iatrogenic embolization following cardiac intervention: postmortem analysis of 110 cases. Cardiovascular Pathology. 40. 12–18. 7 indexed citations
4.
5.
Larouche, Maryse, Cameron Hague, Hamid Masoudi, & Roxana Geoffrion. (2016). Aggressive angiomyxoma presenting as massive irreducible vaginal prolapse. International Urogynecology Journal. 27(12). 1933–1934. 3 indexed citations
6.
Kojic, Liliana D., Simon K. Chan, Terry P Phang, et al.. (2015). Prognostic significance of autocrine motility factor receptor expression by colorectal cancer and lymph node metastases. The American Journal of Surgery. 209(5). 884–889. 5 indexed citations
7.
Sheffield, Brandon S., Hamid Masoudi, Blair Walker, & Sam M. Wiseman. (2014). Preoperative diagnosis of thyroid nodules using the Bethesda System for Reporting Thyroid Cytopathology: a comprehensive review and meta-analysis. Expert Review of Endocrinology & Metabolism. 9(2). 97–110. 40 indexed citations
8.
Chiu, Connie G., Simon K. Chan, Zhe Fang, et al.. (2012). Beta-catenin expression is prognostic of improved non–small cell lung cancer survival. The American Journal of Surgery. 203(5). 654–659. 17 indexed citations
9.
Renouf, Daniel J., et al.. (2009). Küçük Hücreli Dışı Akciğer Kanserinde BCL-2 Ekspresyonu İyi Sağkalım İçin Belirleyicidir. Journal of Thoracic Oncology. 1(1). 39–45. 1 indexed citations
10.
Renouf, Daniel J., Richard Wood‐Baker, Diana N. Ionescu, et al.. (2009). BCL-2 Expression is Prognostic for Improved Survival in Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 4(4). 486–491. 29 indexed citations
11.
Joshi, Bharat, Scott S. Strugnell, Jacky G. Goetz, et al.. (2008). Phosphorylated Caveolin-1 Regulates Rho/ROCK-Dependent Focal Adhesion Dynamics and Tumor Cell Migration and Invasion. Cancer Research. 68(20). 8210–8220. 218 indexed citations
12.
Law, Jennifer, Golareh Habibi, Kaiji Hu, et al.. (2008). Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival. Cancer Research. 68(24). 10238–10246. 339 indexed citations
13.
Griffith, Obi L., Hamid Masoudi, Allen M. Gown, et al.. (2008). Clinical utility of type 1 growth factor receptor expression in colon cancer. The American Journal of Surgery. 195(5). 604–610. 18 indexed citations
14.
Wiseman, Sam M., Obi L. Griffith, Adrienne Melck, et al.. (2008). Evaluation of type 1 growth factor receptor family expression in benign and malignant thyroid lesions. The American Journal of Surgery. 195(5). 667–673. 18 indexed citations
15.
Wiseman, Sam M., Adrienne Melck, Hamid Masoudi, et al.. (2008). Molecular Phenotyping of Thyroid Tumors Identifies a Marker Panel for Differentiated Thyroid Cancer Diagnosis. Annals of Surgical Oncology. 15(10). 2811–2826. 41 indexed citations
16.
Rimsza, Lisa M., Pedro Farinha, Deborah Fuchs, et al.. (2007). HLA-DR protein status predicts survival in patients with diffuse large B-cell lymphoma treated on the MACOP-B chemotherapy regimen. Leukemia & lymphoma. 48(3). 542–546. 36 indexed citations
17.
Farinha, Pedro, Elı́as Campo, Alison H. Banham, et al.. (2006). The architectural pattern of FOXP3(+) T cells is an independent predictor of survival in patients with follicular lymphoma (FL). Modern Pathology. 19. 6 indexed citations
18.
Wiseman, Sam M., Hamid Masoudi, Dmitry Turbin, et al.. (2006). Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma. The American Journal of Surgery. 191(5). 581–587. 43 indexed citations
19.
Wiseman, Sam M., Hamid Masoudi, Dmitry Turbin, et al.. (2006). Anaplastic Thyroid Carcinoma: Expression Profile of Targets for Therapy Offers New Insights for Disease Treatment. Annals of Surgical Oncology. 14(2). 719–729. 96 indexed citations
20.
Farinha, Pedro, Hamid Masoudi, Brian Skinnider, et al.. (2005). Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood. 106(6). 2169–2174. 376 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fatima Rangwala Breakdown of academic impact, for papers by Susan J. Hsiao Breakdown of academic impact, for papers by Armelle Logié Breakdown of academic impact, for papers by Rajiv Bassi Breakdown of academic impact, for papers by Kathryn O’Reilly Breakdown of academic impact, for papers by Michelle Kuhne Breakdown of academic impact, for papers by Ellen Leich Breakdown of academic impact, for papers by Khuda Dad Khan Breakdown of academic impact, for papers by Carlos García-Echeverría Breakdown of academic impact, for papers by Xenia Jimenez
Rankless by CCL
2026